PACAP(6-38) inhibits the growth of prostate cancer cells

Cancer Letters

Volumn 125, Issue 1-2, 1998, Pages 131-139

  Leyton, J ^a   Coelho, T ^a   Coy, D H ^b   Jakowlew, S ^a   Birrer, M J ^a   Moody, T W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

PACAP; Proliferation; Prostate cancer; Receptor antagonist; VIP

Indexed keywords

CYCLIC AMP; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27;

ARTICLE; CANCER CELL; GENE EXPRESSION; GROWTH INHIBITION; ONCOGENE C FOS; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL DIVISION; CYCLIC AMP; GENES, FOS; HUMANS; MALE; NEUROPEPTIDES; PEPTIDE FRAGMENTS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PROSTATIC NEOPLASMS; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; RECEPTORS, PITUITARY HORMONE; RNA, MESSENGER; TUMOR CELLS, CULTURED; VASOACTIVE INTESTINAL PEPTIDE;

MUS MUSCULUS;

EID: 0032513176     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00525-9     Document Type: Article

References (33)

1. Said S.I., Mutt V. Polypeptide with broad biological activity: isolation from the small intestine. Science. 69:1970;1217-1218.
2. Miyata A., Amimura A., Dahl R.R., Uehara A., Jiang L., Culler M.D., Coy D.H. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164:1989;567-574.
3. Miyata A., Jiang L., Dahl R.R., Kitada C., Kubo K., Fujino M., Minamino N., Arimura A. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP-38). Biochem. Biophys. Res. Commun. 170:1990;643-648.
4. Pisegna J.R., Wank S.A. Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor. Proc. Natl. Acad. Sci. USA. 90:1993;6345-6349.
5. Spengler D., Waeber C., Pantaloni C., Holsboer F., Bockaert J., Seeberg P.H., Journot L. Differential signal transduction by five splice variants of the PACAP receptor. Nature. 365:1993;170-175.
6. Ishihara T., Shigemoto R., Mori K., Takahashi K., Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron. 8:1992;811-819.
7. Harmar T., Lutz E. Multiple receptors for PACAP and VIP. Trends Pharmacol. Sci. 15:1994;97-99.
8. Christophe J. Type I receptors for PACAP (a neuropeptide even more important than VIP?). Biochim. Biophys. Acta. 1154:1993;183-199.
9. Vaalasti A., Tainio H., Pelto-Huikko M., Hervonen A. Light and electron microscope demonstration of VIP- and enkephalin-immunoreactive nerves in the human male genitourinary tract. Anat. Rec. 215:1986;21-27.
10. Chapple C.R., Crowe R., Gilpin S.A., Gosling J., Burnstock G. The innervation of human prostate gland. The changes associated with benign enlargement. J. Urol. 146:1991;1637-1644.
11. Carmena M.J., Prieto J.C. Cyclic AMP-stimulating effect of vasoactive intestinal peptide in isolated epithelial cells of rat ventral prostate. Biochim. Biophys. Acta. 763:1983;414-418.
12. Carmena M.J., Sancho J.I., Prieto J.C. Effects of age and androgens upon function vasoactive intestinal peptide receptors in rat prostatic epithelial cells. Biochem. Biophys. Acta. 888:1986;338-343.
13. Prieto J.C., Carmena M.J. Receptors for vasoactive intestinal peptide on isolated epithelial cells of rat ventral prostate. Biochim. Biophys. Acta. 763:1983;408-413.
14. Juarranz M.G., Guijarrao L.G., Bajo A.M., Carmena M.J., Prieto J.C. The ontogeny of vasoactive intestinal peptide receptors in rat ventral prostate. Gen. Pharmacol. 25:1994;509-514.
15. Solano R.M., Carmena M.J., Carrero I., Cavallaro S., Roman F., Hueso C., Travali S., Lopez-Fraile N., Guijarro L.G., Prieto J.C. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate. Endocrinology. 137:1996;2815-2822.
16. Hoosein N.M., Logothetis C.J., Chung I.W.K. Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells. J. Urol. 149:1993;1209-1213.
17. Moody T.W., Zia F., Brenneman D., Fridkin M., Davidson A., Gozes I. A VIP antagonist inhibits the growth of non-small cell lung cancer. Proc. Natl. Acad. Sci. USA. 90:1993;4345-4349.
18. Shaffer M.M., Carney D.N., Korman L.Y., Lebovic G.S., Moody T.W. High affinity binding of VIP to human lung cancer cell lines. Peptides. 8:1987;1101-1106.
19. Lee M., Jensen R.T., Huang S.C., Bepler G., Korman L., Moody T.W. Vasoactive intestinal polypeptide binds with high affinity to non-small cell lung cancer cells and elevates cyclic AMP levels. Peptides. 11:1990;1205-1209.
20. Angelberger P., Banyai M., Banyai S., Kurtaran A., Li S., Pidlich J., Raderer M., Virgolini I., Yang Q., Niederle B., Scheithauer W., Valent P. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. N. Engl. J. Med. 331:1994;1116-1121.
21. Zia H., Hida T., Jakowlew S., Birrer M., Gozes Y., Reubi J.C., Fridkin M., Gozes I., Moody T.W. Breast cancer growth is inhibited by VIP hybrid, a synthetic VIP receptor antagonist. Cancer Res. 56:1996;3486-3489.
22. C. Bellan, C. Fabre, J. Luis, J. Marvaldi, Pharmacological characterization of a new type of VIP receptor on the melanoma-derived cell line IGR37, in: G. Rosselin (Ed.), VIP, PACAP & Related Peptides: From Molecular Biology to Clinical Applications, World Scientific, Singapore, 1994, pp. 179-186.
23. M. Li, L.Q. Zheng, M. Hoshino, M. Suzuki, K. Iguchi, C. Yanaihara, T. Mochizuki, N. Yanihara, Helodermin receptors on human neuroblastoma NB-OK-1 cells, in: G. Rosselin (Ed.), VIP, PACAP & Related Peptides: From Molecular Biology to Clinical Applications, World Scientific, Singapore, 1994, pp. 173-178.
24. Gespatch C., Emami S., Rosselin G. Gastric inhibitory peptide (GIP), pancreatic glucagon, and vasoactive intestinal peptide (VIP) are cAMP-inducing hormones in the human gastric cancer cell line HGT-1. Homologous desensitization of VIP receptor activity. Biochem. Biophys. Res. Commun. 120:1984;641-649.
25. Moody T.W., Zia F., Makheja A. PACAP elevates cytosolic calcium in small cell lung cancer cell lines. Peptides. 14:1993;241-246.
26. T.W. Moody, F. Zia, K. Bitar, D.H. Coy, PACAP(6-38) is a PACAP type I receptor antagonist on small cell lung cancer cells, in: G. Rosselin (Ed.), VIP, PACAP & Related Peptides: From Molecular Biology to Clinical Applications, World Scientific, Singapore, 1994, pp. 537-544.
27. Zia F., Fagarasan M., Bitar K., Coy D.H., Pisegna J., Wank S., Moody T.W. PACAP receptors regulate the growth of non-small cell lung cancer cells. Cancer Res. 55:1995;4886-4891.
28. Korman L.Y., Carney D.N., Citron M.L., Moody T.W. Secretin/VIP stimulated secretion of bombesin-like peptides from human small cell lung cancer. Cancer Res. 46:1986;1214-1218.
29. Draoui M., Chung P., Park M., Birrer M., Jakowlew S., Moody T.W. Bombesin stimulates c-fos and c-jun mRNAs in small cell lung cancer cells. Peptides. 16:1995;289-292.
30. Szabo E., Preis L.H., Brown P.H., Birrer M.J. The role of jun and fos gene family members in 12-O-tetradecanoylphorbol-13-acetate induced hemopoietic differentiation. Cell Growth Diff. 2:1991;475-482.
31. 13,14)Bombesin analogues inhibit the growth of small cell lung cancer in vitro and in vivo. Cancer Res. 51:1991;1798-1802.
32. Draoui M., Hida T., Jakowlew S., Birrer M., Zia F., Moody T.W. PACAP stimulates c-fos mRNAs in small cell lung cancer cells. Life Sci. 59:1996;307-313.
33. Pisegna J., Wank S. Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor: evidence for dual coupling to adenylate cyclase and phospholipase C. J. Biol. Chem. 271:1996;17267-17274.